Stay updated on KD025 Efficacy and Safety in cGVHD Clinical Trial
Sign up to get notified when there's something new on the KD025 Efficacy and Safety in cGVHD Clinical Trial page.

Latest updates to the KD025 Efficacy and Safety in cGVHD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedDifference2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded the ROCKstar Study citation (Blood, 2021) to the Publications section. Removed the original Blood 2021 entry that has an Erratum published in Blood in 2022.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision: v3.3.2 was added and v3.3.1 was removed; this appears to be a minor update with no impact on study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check38 days agoChange DetectedAdded a note clarifying that publications are automatically filled in from PubMed, and updated the revision version from v3.2.0 to v3.3.1.SummaryDifference0.1%

- Check46 days agoChange DetectedA government funding status notice was removed from the page; all study details, contacts, and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedIn the Publications section, the ROCKstar study reference was updated: the 2021 Blood article by Cutler et al. was removed and a 2022 Blood entry for the related Erratum was added.SummaryDifference0.0%

Stay in the know with updates to KD025 Efficacy and Safety in cGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KD025 Efficacy and Safety in cGVHD Clinical Trial page.